Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by ReCode Therapeutics

< Previous 1 2 Next >
News headline image
ReCode Therapeutics to Present at Upcoming Investor Conferences in 2022
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics Establishes Scientific Advisory Board
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics to Participate in Upcoming November Investor Conferences
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics to Participate in Upcoming October Investor Conferences
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics to Present at Jefferies Cell and Genetic Medicine Summit
From ReCode Therapeutics
Via Business Wire
News headline image
Fierce Biotech Names ReCode Therapeutics as One of its “Fierce 15” Biotech Companies of 2022
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics to Present at Morgan Stanley 20th Annual Global Healthcare Conference
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics to Participate in Upcoming July Investor Conferences
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics to Expand Next-Generation Delivery Platform and Diversify Genetic Medicines Pipeline with Oversubscribed Series B Financing Totaling $200M
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics to Present at Jefferies Healthcare Conference
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics Presents New Preclinical Data from mRNA-based Program for Cystic Fibrosis at the ATS 2022 International Conference
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics Presents Preclinical Data from Inhaled mRNA Therapeutic Program in Primary Ciliary Dyskinesia (PCD) in Three Posters at the ATS 2022 International Conference
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics to Present at 2022 RBC Capital Markets Global Healthcare Conference
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics to Present Preclinical Data Using Proprietary SORT LNP Delivery Platform From Its mRNA-based Therapeutic Programs at the ATS 2022 International Conference in San Francisco
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics Appoints Shehnaaz Suliman, M.D., MBA, M.Phil., as Chief Executive Officer
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics to Participate in Upcoming November Investor Conferences
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics Presents Preclinical Data from mRNA-based Cystic Fibrosis Program at 2021 North American Cystic Fibrosis Conference
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics Raises Oversubscribed Series B Financing Round of $80 Million
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics to Present Preclinical Data from mRNA-based Program for Cystic Fibrosis at Upcoming Virtual 2021 North American Cystic Fibrosis Conference
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics Announces Participation in Upcoming October Investor Conferences
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics Appoints Nicholas P. France, M.D., as Senior Vice President of Clinical Development
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics Announces Participation in Upcoming Investor Conferences
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics Appoints Angèle Maki, Ph.D., as Senior Vice President of Business Development
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics Presents Encouraging Preclinical Data from Inhaled mRNA Therapeutics Program in Primary Ciliary Dyskinesia at the 2021 PCD on the Move Virtual Scientific Conference
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics to Participate in Upcoming August Investor Conferences
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics to Present Preclinical Data from mRNA-Based Program for Primary Ciliary Dyskinesia at the 2021 PCD on the Move Virtual Scientific Conference
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics to Present at William Blair Biotech Focus Conference 2021
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics to Participate in Upcoming June Investor Conferences
From ReCode Therapeutics
Via Business Wire
News headline image
ReCode Therapeutics Presents Preclinical Data Using SORT-LNP™ and RNA Platforms to Rescue CFTR Function at the 44th European Cystic Fibrosis Conference (ECFS)
From ReCode Therapeutics
Via Business Wire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.